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Background. Sputum smear microscopy is commonly used for diagnosing tuberculosis (TB). Although patients
with sputum smear–negative TB are less infectious than patients with smear-positive TB, they also contribute to
TB transmission. The objective of this study was to determine the proportion of TB transmission events caused
by patients with smear-negative pulmonary TB in The Netherlands.
Methods. All patients in The Netherlands with culture-confirmed TB during the period 1996–2004 were
included in this study. Patients with identical DNA fingerprints in Mycobacterium tuberculosis isolates from sputum
samples were clustered. The first patients in a cluster were considered to be the index patients; all other patients
were considered to have secondary cases. In addition, we examined transmission from sources by conventional
contact tracing.
Results. We analyzed 394 clusters with a total of 1285 patients. On the basis of molecular linkage only, 12.6%
of the secondary cases were attributable to transmission from a patient with smear-negative TB. The relative
transmission rate among patients with smear-negative TB, compared with patients with smear-positive TB, was
0.24 (95% confidence interval, 0.20–0.30). Secondary cases in clusters with an index patient with smear-negative
TB more frequently had smear-negative status (odds ratio, 1.86; 95% confidence interval, 1.18–2.93), compared
with secondary cases in clusters with an index patient with smear-positive TB. Conventional contact tracing revealed
that 26 (6.2%) of the 417 sources, as identified by the Municipal Health Services, had smear-negative TB.
Conclusions. In The Netherlands, patients with smear-negative, culture-positive TB are responsible for 13%
of TB transmission. Countries that have ample resources should expand their TB-control efforts to include
prevention of transmission from patients with smear-negative, culture-positive pulmonary TB.
Mycobacterium tuberculosis is mainly transmitted by pa-
tients with pulmonary tuberculosis (TB). Microscopic
examination of sputum smear specimens for the pres-
ence of M. tuberculosis, observed as acid-fast bacilli, is
used worldwide to diagnose TB. Patients with sputum
smear–negative TB are less infectious than patients with
sputum smear–positive TB [1, 2]. Nevertheless, patients
with smear-negative, culture-positive pulmonary TB
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are capable of transmitting M. tuberculosis [3, 4]. Light
microscopy can detect mycobacteria at a minimum
density of 5000–10,000 bacilli per mL of sputum,
whereas the infectious amount is only a few organisms
[5, 6]. Therefore, persons in contact with patients with
smear-negative TB are at risk of infection due to M.
tuberculosis and the subsequent development of active
TB [2, 7, 8]. However, there are limited quantitative
data on the relative contribution of patients with smear-
negative, culture-positive TB to TB transmission.
Recent studies in San Francisco [3] and Vancouver
[4] that used molecular linkage estimated that, for
17%–20% of patients with TB, TB resulted from trans-
mission by patients with smear-negative TB. However,
these studies analyzed only 71 and 44 clusters,
respectively.
In our study, we expanded on these observations by
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determining the contribution of patients with smear-negative,
culture-positive TB to TB transmission in a large cohort in The
Netherlands with use of both molecular linkage and data from
contact investigations performed by the Municipal Health Ser-
vices. The advantage of studying this topic among a large na-
tional TB cohort is the added confidence that may be gained
by the large number of patients studied over a long period.
METHODS
Patients. Demographic and clinical information for all pa-
tients with TB diagnosed in The Netherlands during the period
1996–2004 was retrieved from The Netherlands Tuberculosis
Register (NTR).
Molecular linkage. M. tuberculosis isolates from all patients
with TB who had a positive culture result were subjected to
standardized IS6110-based restriction fragment–length poly-
morphism typing to disclose linkage between patients with TB,
as described elsewhere [9, 10]. Isolates with 4 IS6110 bands
were subtyped using the polymorphic GC-rich sequence as a
probe. Patients whose M. tuberculosis isolates had 100% iden-
tical DNA fingerprints were clustered. In general, the first pa-
tient who received a diagnosis in a cluster was considered to
be the index patient of that cluster.
The Beijing genotype was defined as described elsewhere
[11]. The Haarlem genotype was defined according to IS6110
restriction fragment–length polymorphism and spoligotype
patterns [12] and sequencing of the ogt gene [13].
Cluster selection. Data from the NTR were matched with
data from the national M. tuberculosis DNA fingerprint database
on the basis of sex, date of birth, date of TB diagnosis, and
postal code, as described elsewhere [14]. Patients with a unique
M. tuberculosis DNA fingerprint and clusters in which the index
patient had only extrapulmonary TB were excluded from the
analysis. Because sputum smear status has only been recorded
in the NTR since 1996, we included only clusters from during
or after 1996. To increase the chance that only new clusters
were included, we excluded all clusters including cases from
the period 1993–1995. No ethical approval was needed, because
we used retrospectively gathered anonymous data.
Proportion of transmission caused by patients with smear-
negative status. Our primary epidemiological outcome was
the proportion of TB transmission caused by patients with
smear-negative status. The transmission events associated with
patients with smear-negative status were only calculated for
clusters in which the smear status of the index patient was
known. Secondary cases that were preceded only by cases of
smear-negative TB were attributed to smear-negative trans-
mission (i.e., transmission from a patient with smear-negative
TB). All cases that occurred after any case of smear-positive
TB were attributed to smear-positive transmission (i.e., trans-
mission from a patient with smear-positive TB). For clusters
in which the index patient’s smear status was unknown, we
used the 2 following extreme approaches as a sensitivity anal-
ysis: we determined the proportion of smear-negative trans-
mission events assuming that all unknown smear results were
positive, and we determined the proportion of smear-negative
transmission events assuming that all unknown smear results
were negative.
Relative transmission rate. Our secondary outcome was
the relative rate of transmission by patients with smear-negative
status. This rate indicates the proportion of transmission that
is caused by patients with smear-negative TB, compared with
the proportion caused by patients with smear-positive TB. The
relative transmission rate was calculated as the number of
smear-negative transmission events per the total number of
patients with smear-negative TB divided by the number of
smear-positive transmission events per the total number of
patients with smear-positive TB. The relative transmission rate
was calculated by using all patients from the matched database,
with exclusion of only those patients with extrapulmonary TB,
because they did not have a smear result recorded in the NTR.
Sensitivity analysis. We corrected our primary outcome,
the proportion of smear-negative transmission events, for 2
possible biases. The reversed-order-of-diagnosis bias would
most likely occur in clusters in which the first 2 patients had
cases diagnosed within a few months of each other [3]. There-
fore, we sequentially removed all clusters in which the first 2
cases were diagnosed within 1, 2, 3, 4, 5, or 6 months of each
other and recalculated the proportion of smear-negative trans-
mission events.
When the first 2 cases in a cluster are diagnosed 12 years
apart, it is unlikely that the second case would result from
recent transmission by the patient with the first case [15]. To
determine the effect of this no-recent-transmission bias, we
sequentially removed all clusters in which the first 2 cases were
diagnosed 12, 3, 4, and 5 years apart and recalculated the
proportion of smear-negative transmission events.
Epidemiological linkage. Clustered patients with TB are
systematically reported to the Municipal Health Services. TB
public health nurses contact these patients to investigate pos-
sible epidemiological links with previous patients in that same
DNA fingerprint cluster with use of standardized questionnaires
[16]. If an epidemiological link is found between 2 clustered
patients with TB, the index patient is registered as a source,
and the patient with the secondary case is registered as a contact.
A source is defined as a definite source if the source and the
contact know each other’s name, and the source is defined as
a probable source if the source and the contact do not know
each other’s name but share an identical risk factor (e.g., lo-
cation visited or risk group) [16]. We calculated the proportion
of patients with smear-negative TB among all sources, as de-
fined by the Municipal Health Service.
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Figure 1. Flow chart of patient and cluster selection. E, extrapulmon-
ary; P, pulmonary; RIVM, Mycobacteria Reference Laboratory at the Na-
tional Institute for Public Health and the Environment (Bilthoven, The
Netherlands); TB, tuberculosis.
Statistical analysis. To study possible risk factors for being
in a cluster with an index patient with smear-negative TB, we
used logistic regression to calculate ORs for the categorical
variables, and depending on the distribution, we used either
Student’s t test or the Mann-Whitney U test for numerical
variables. A threshold of was used to define statisticalP ! .05
significance. All analyses were performed with use of SPSS for
Windows, version 14.0 (SPSS).
RESULTS
Patients. The NTR contained 13,064 patients with all forms
of TB from January 1996 through December 2004; 9139
(70.0%) of these patients had culture-positive TB. The National
Institute for Public Health and the Environment determined
the DNA fingerprint of 9347 M. tuberculosis isolates during this
period. We matched the NTR database to the DNA fingerprint
database, which resulted in a matched database of 7438 patients
with TB. Because DNA fingerprinting can only be performed
for patients with culture-positive TB, 7438 (81.4%) of 9139
patients with culture-confirmed TB were matched. Exclusion
of all patients with a unique DNA fingerprint, who were in a
cluster that started before 1996, or who were in a cluster in
which the index patient had only extrapulmonary TB resulted
in a database of 394 clusters with a total of 1285 patients (figure
1).
Molecular linkage. Compared with index patients with
smear-positive TB, index patients with smear-negative TB more
frequently had pulmonary and extrapulmonary TB (OR, 2.58;
95% CI, 1.40–4.78) and were less frequently born in The Neth-
erlands (OR, 0.52; 95% CI, 0.28–0.95) (table 1). Secondary
cases in clusters with an index patient with smear-negative TB
were more likely to have smear-negative TB (OR, 1.86; 95%
CI, 1.18–2.93) and were more frequently 155 years of age (OR,
1.87; 95% CI, 1.16–3.00), compared with secondary cases in
clusters with an index patient with smear-positive TB (table 2).
The median time from diagnosis of the first case to diagnosis
of the second case was significantly shorter in clusters with an
index patient with smear-positive TB than in clusters with an
index patient with smear-negative TB (533 vs. 216 days, re-
spectively; ) (table 3). The smear status of the indexP ! .001
patient was not associated with characteristics of the M. tu-
berculosis genotype family, because the proportion of Haarlem
or Beijing strain did not differ between clusters with an index
patient with smear-positive TB and clusters with an index pa-
tient with smear-negative TB.
Proportion of smear-negative transmission events. In to-
tal, 359 (91.1%) of the 394 clusters had an index patient with
a known smear result, and these index patients lead to 844
secondary cases (table 4). Ninety-two clusters had an index
patient with smear-negative status, and 106 (70.7%) of the 150
secondary cases were attributable to transmission from a pa-
tients with smear-negative status. The proportion of smear-
negative transmission events was 12.6% (106 of 844 secondary
cases resulted smear-negative transmission).
If all unknown smear results were assumed to be negative,
171 (19.2%) of 891 transmission events would have been smear
negative. Alternatively, if all unknown smear results were as-
sumed to be positive, no extra smear-negative transmission
events would have occurred (i.e., 106 [11.9%] of the total 891
transmission events would have been smear negative) (table 4).
Sensitivity analysis. After correction for possible reversed-
order-of-diagnosis bias, the proportion of smear-negative trans-
mission events increased from 12.1% to 18.0%. After correction
for possible no-recent-transmission bias, the proportion of
smear-negative transmission events decreased from 12.3% to
8.7%.
Relative transmission rate. The relative transmission rate
was calculated using all 7438 patients from the matched da-
tabase. Of these patients, 3890 (52.3%) had pulmonary TB,
2530 (34.0%) had extrapulmonary TB, and 791 (10.6%) had
pulmonary and extrapulmonary TB; data were missing for 227
patients (3.0%).
Overall, 1614 patients had smear-negative TB, and 2734 pa-
tients had smear-positive TB. Dividing the 106 smear-negative
transmission events that occurred in the 1614 patients with
smear-negative TB by the 739 smear-positive transmission
events that occurred in the 2734 patients with smear-positive
TB resulted in a relative transmission rate of 0.24 (95% CI,
0.20–0.30). This means that patients with smear-negative pul-
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Table 1. Characteristics of the index patients.
Characteristic
No. (%) of index patients, by smear status
OR (95% CI)a
Positive
(n p 267)
Negative
(n p 92)
Unknown
(n p 35)
All
(n p 394)
Age, years
0–14 4 (1.5) 1 (1.1) 2 (5.7) 7 (1.8) 0.82 (0.09–7.49)
15–34 157 (58.8) 48 (52.2) 17 (48.6) 222 (56.3) 1
35–54 60 (22.5) 23 (25.0) 4 (11.4) 87 (22.1) 1.25 (0.70–2.24)
55 46 (17.2) 20 (21.7) 12 (34.3) 78 (19.8) 1.42 (0.77–2.63)
HIV status
Positive 16 (6.0) 8 (8.7) 1 (2.9) 25 (6.3) 1.49 (0.61–3.63)
Negative 27 (10.1) 9 (9.8) 8 (22.9) 44 (11.2) 1.00 (0.45–2.21)
Unknown 224 (83.9) 75 (81.5) 26 (74.3) 325 (82.5) 1
Tuberculosis siteb
Pulmonary 235/264 (89.0) 69/91 (75.8) 26 (74.3) 330/390 (84.6) 1
Pulmonary and extrapulmonary 29/264 (11.0) 22/91 (24.2) 9 (25.7) 60/390 (15.4) 2.58 (1.40–4.78)
Sex
Male 168 (62.9) 51 (55.4) 26 (74.3) 245 (62.2) 0.73 (0.45–1.19)
Female 99 (37.1) 41 (44.6) 9 (25.7) 149 (37.8) 1
Born in The Netherlands
No 187 (70.0) 75 (81.5) 20 (57.1) 282 (71.6) 1
Yes 77 (28.8) 16 (17.4) 15 (42.9) 108 (27.4) 0.52 (0.28–0.95)
Missing data 3 (1.1) 1 (1.1) 0 (0) 4 (1.0) 0.83 (0.09–8.12)
a The univariate ORs were calculated for patients in clusters with an index patient with smear-negative tuberculosis versus patients
in clusters with an index patient with smear-positive tuberculosis. Clusters in which the smear status of the index patient was unknown
were not considered in these analyses.
b The tuberculosis site was not known for all patients.
monary TB were only 0.24 times as likely to spread TB as
patients with smear-positive pulmonary TB.
Epidemiological linkage. From 1996 through 2004, the TB
services of the Municipal Health Services identified 517 source
patients during investigation of contacts among clustered pa-
tients with TB. Four hundred seventeen of these patients
matched with our final database. A source patient was defined
as a definite source of a case in another patient if the 2 patients
knew each other by name and as a probable source if they did
not know each other by name but had been in the same lo-
cation. Twenty (5.4%) of the 369 definite sources and 6 (12.5%)
of the 48 probable sources had smear-negative TB. Overall, 26
(6.3%) of the 417 sources had smear-negative TB.
DISCUSSION
Our study revealed that 12.6% of the TB transmission in The
Netherlands is caused by patients with smear-negative pul-
monary TB. In clusters with an index patient with smear-neg-
ative status, almost 71% of the secondary cases were attributable
to smear-negative transmission.
The conclusions of this study provide strong evidence that
TB can be transmitted from patients with smear-negative status,
confirming and expanding previous observations from smaller,
urban studies [3, 4]. In this respect, 3 independent studies in
different settings converge on the conclusion that patients with
smear-negative TB lead to approximately one-quarter as many
cases of TB as do patients with smear-positive TB and are
responsible for 10%–20% of transmission. We consider this
result to be important for both developed and developing
countries.
An intriguing finding is that, compared with index patients
with smear-positive TB, index patients with smear-negative TB
were associated with a disproportionate number of secondary
cases with smear-negative TB (table 2). The reasons for this
are not clear, although one possible explanation could be coin-
fection with HIV, because HIV infection is accompanied by
high rates of smear-negative TB [17]. Unfortunately, because
HIV status was unknown for the vast majority of the patients
in our cohort, we could not analyze this possible explanation.
Furthermore, bacteriological factors may have caused some
clusters to have more patients with smear-negative TB than
other clusters. In particular, we expected the Beijing strain to
be more common in clusters with an index patient with smear-
positive TB, because the Beijing genotype is associated with
high virulence, relapse, and treatment failure [18]. The Beijing
genotype was observed in 9.0% of the clusters with an index
patient with smear-positive TB, compared with 4.3% of the
clusters with an index patient with smear-negative TB, but this
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Table 2. Characteristics of the secondary cases.
Characteristic
No. (%) of secondary cases,
by smear status of the index patient
OR (95% CI)a
Positive
(n p 694)
Negative
(n p 150)
Unknown
(n p 47)
All
(n p 891)
Smear status
Positive 277 (39.9) 44 (29.3) 14 (29.8) 335 (37.6) 1
Negative 159 (22.9) 47 (31.3) 12 (25.5) 218 (24.5) 1.86 (1.18–2.93)
Missing data 258 (37.2) 59 (39.3) 21 (44.7) 338 (37.9) 1.44 (0.94–2.20)
Age, years
0–14 40 (5.8) 3 (2.0) 6 (12.8) 49 (5.5) 0.37 (0.11–1.22)
15–34 377 (54.3) 77 (51.3) 19 (40.4) 473 (53.1) 1
35–54 193 (27.8) 38 (25.3) 10 (21.3) 241 (27.0) 0.96 (0.63–1.48)
55 84 (12.1) 32 (21.3) 12 (25.5) 128 (14.4) 1.87 (1.16–3.00)
HIV status
Positive 34 (4.9) 6 (4.0) 1 (2.1) 41 (4.6) 0.78 (0.32–1.90)
Negative 74 (10.7) 12 (8.0) 7 (14.9) 93 (10.4) 0.72 (0.38–1.36)
Unknown 586 (84.4) 132 (88.0) 39 (83.0) 757 (85.0) 1
Tuberculosis siteb
Pulmonary 390/635 (61.4) 76/136 (55.9) 17/46 (37.0) 483/817 (59.1) 1
Pulmonary and extrapulmonary 67/635 (10.6) 13/136 (9.6) 10/46 (21.7) 90/817 (11.0) 1.00 (0.52–1.89)
Extrapulmonary 178/635 (28.0) 47/136 (34.6) 19/46 (41.3) 244/817 (29.9) 1.36 (0.90–2.03)
Sex
Male 462 (66.6) 92 (61.3) 29 (61.7) 583 (65.4) 0.80 (0.55–1.15)
Female 232 (33.4) 58 (38.7) 18 (38.3) 308 (34.6) 1
Born in The Netherlands
No 414 (59.6) 99 (66.0) 22 (46.8) 535 (60.0) 1
Yes 221 (31.8) 37 (24.7) 24 (51.1) 282 (31.6) 0.70 (0.46–1.06)
Missing data 59 (8.5) 14 (9.3) 1 (2.1) 74 (8.3) 0.99 (0.53–1.85)
a The univariate ORs were calculated for patients in clusters with an index patient with smear-negative tuberculosis versus patients in
clusters with an index patient with smear-positive tuberculosis. Clusters in which the smear status of the index patient was unknown were
not considered in these analyses.
b The tuberculosis site was not known for all patients.
difference was not statistically significant (OR, 0.46; 95% CI,
0.16–1.36). The small number of clusters with a patient who
was positive for the Beijing strain (32 of the 394 clusters) in
our database imposed an unfortunate limitation on our
analysis.
Secondary cases associated with an index patient with smear-
negative TB were older than secondary cases associated with
an index patient with smear-positive TB. It is possible that the
pathogenesis of TB in older people may differ from that in
young people. More index patients with smear-negative TB
than index patients with smear-positive TB were born outside
The Netherlands. Perhaps a more extended time between in-
fection and disease manifestation plays a role in this. This find-
ing may also be related to the fact that more patients with TB
who are born abroad more frequently have smear-negative TB,
compared with patients with TB who are born in The
Netherlands.
Hernandez-Garduno et al. [4] either included or excluded
all patients with only extrapulmonary TB in their analyses.
Patients with extrapulmonary TB most likely do not transmit
TB unless the pulmonary site is unnoticed. Therefore, we ex-
cluded only the index patients with extrapulmonary TB only
and not the secondary cases with extrapulmonary TB.
When using the epidemiological linkage data, only 6.3% of
patients with TB had TB caused by transmission from a patient
with smear-negative TB; the results of our molecular analysis
indicate that 12.6% of patients with TB contracted TB from a
patient with smear-negative TB. This difference is likely to be
attributable to epidemiological links failing to reveal all contacts
(e.g., unknown casual contacts).
The relative transmissibility of TB from patients with smear-
negative TB was 0.24 (95% CI, 0.20–0.30), which confirms the
relative transmission rate of 0.22 (95% CI, 0.16–0.32) that was
found in Behr et al. [3]. This rate has implications for countries
with a low incidence of TB, especially those countries where
the patient’s smear status determines the isolation measures
and the extent of contact investigation. In The Netherlands,
contact tracing is performed for all patients with TB, except
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Table 3. Characteristics of the clusters.
Variable
Index patients, by smear status
OR (95%CI)a
Positive
(n p 267)
Negative
(n p 92)
Unknown
(n p 35)
All
(n p 394)
Cluster size
2–4 224 (83.9) 86 (93.5) 35 (100) 345 (87.6) 1
5–10 32 (12.0) 6 (6.5) 0 (0) 38 (9.6) 0.49 (0.20–1.20)
11–20 6 (2.2) 0 (0) 0 (0) 6 (1.5) …
21–50 5 (1.9) 0 (0) 0 (0) 5 (1.3) …
Time between diagnosis of the first case to diagnosis
of the second case, median days (IQR)b 216 (69–672) 533 (221–1201) 410 (74–957) … …
Beijing genotype
Yes 24 (9.0) 4 (4.3) 4 (11.4) 32 (8.1) 0.46 (0.16–1.36)
No 243 (91.0) 88 (95.7) 31 (88.6) 362 (91.9) 1
Haarlem genotype
Yes 50 (18.7) 16 (17.4) 6 (17.1) 72 (18.3) 0.91 (0.49–1.70)
No 217 (81.3) 76 (82.6) 29 (82.9) 322 (81.7) 1
NOTE. Data are no. (%) of patients, unless otherwise indicated. IQR, interquartile range.
a The ORs were calculated for patients in clusters with an index patient with smear-negative tuberculosis versus patients in clusters with an index patient
with smear-positive tuberculosis, using univariate logistic regression. Clusters in which the smear status of the index patient was unknown were not considered
in these analyses.
b .P ! .001
for patients with extrapulmonary TB for whom transmission
can be practically excluded (e.g., vertebral TB). In The Neth-
erlands, contact tracing is performed for both patients with
smear-negative TB and patients with smear-positive TB; how-
ever, this is not the case in many other countries with a low
incidence of TB.
Our study revealed that this contact-tracing policy is justified.
Not only do the workers at a TB service search for patients
with TB (i.e., contact tracing), they also search for the possible
source patient. Contact tracing starts in the so-called first ring,
which includes the closest contacts to the patients with TB,
and is then expanded to the next ring, according to the yield
of the ring [19]. The infectiousness of patients with smear-
negative TB is especially important in light of multidrug-re-
sistant and extremely drug-resistant TB; therefore, it is highly
advisable to perform contact tracing for all patients with these
forms of drug-resistant TB, irrespective of their smear status.
Our study was based on several assumptions. The first as-
sumption was that the first patient in a cluster is the index
patient of that cluster. This may not always be true. For ex-
ample, the real source patient of that cluster could have received
a diagnosis before the start of the study period. To increase the
chance that only new clusters were included, we excluded all
clusters in which there were patients from the period 1993–
1995. Furthermore, patients with an identical DNA fingerprint
may not have necessarily infected each other. Some strains are
common among specific ethnic groups in The Netherlands,
and these may be circulating strains in some patients’ countries
of origin. Therefore, there could have been more clusters of
patients with identical DNA fingerprints that were not the result
of transmission between the patients in the cluster. Because this
might have occurred to the same extent in clusters with either
index patients with smear-positive TB or index patients with
smear-negative TB, we assume that this would have only a
limited effect on our data. Sensitivity analyses revealed that
both reversed-order-of-diagnosis bias and no-recent-transmis-
sion bias may have occurred in our study to a limited extent;
thus, the outcome could be slightly overestimated or
underestimated.
Approximately 68% of all patients with TB in The Nether-
lands have culture-confirmed TB; DNA fingerprinting can be
performed only for those patients. Comparison of the 2 da-
tabases resulted in a match for 7438 (81.4%) of the 9139 pa-
tients with culture-positive TB. This was concordant with a
similar matching procedure performed with use of these same
databases, by which no differences in sex, age, and nationality
were found between patients with culture-confirmed TB who
matched and patients with culture-confirmed TB who did not
match [14]. Nonmatches were probably largely attributable to
registration errors and, to a lesser extent, to patients not being
registered in 1 of the 2 databases.
In The Netherlands, ∼80% of the laboratories use fluores-
cence microscopy. Fluorescence microscopy is more sensitive
than conventional microscopy and will therefore detect more
cases of smear-positive TB [20]. It is possible that, among the
20% of patients in our study cohort who had their cases di-
agnosed with use of conventional microscopy, fewer patients
would have been determined to have smear-negative TB if their
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Table 4. Transmission events, by smear status of the index patients.
Variable
No. of secondary cases, by smear
status of the index patient
Positive Negative Unknown All
Total 694 150 47 891
Clusters with an index patient with smear-positive or smear-negative TB only
Secondary case attributable to smear-positive transmission 694 44 0 738
Secondary case attributable to smear-negative transmission 0 106 0 106
All 694 150 0 844
If all patients with unknown smear results were considered to have smear-positive TB
Secondary case attributable to smear-positive transmission 694 44 47 738
Secondary case attributable to smear-negative transmission 0 106 0 106
All 694 150 47 891
If all patients with unknown smear results were considered to have smear-negative TB
Secondary case attributable to smear-positive transmission 694 21 5 720
Secondary case attributable to smear-negative transmission 0 129 42 171
All 694 150 47 891
NOTE. The total number of index patients was 394; 267 had positive smear status, 92 had negative smear status, and 35 had unknown smear
status. The total number of patients was 1285; 961 had positive smear status, 242 had negative smear status, and 82 had unknown smear status.
The proportion of smear-negative transmission events was calculated by dividing the number of smear-negative transmission events by the total number
of transmission events, using the 3 different scenarios shown. The proportion of smear-negative transmission events was 12.6% (106 of 844 secondary
cases were attributable to smear-negative transmission), the proportion of smear-negative transmission events was 11.9% (106 of 891), and the
proportion of smear-negative transmission events was 19.2% (171 of 891). TB, tuberculosis.
cases were diagnosed with use of fluorescence microscopy. Be-
cause the microscopy technique used for diagnosis is not reg-
istered in the NTR, we could not determine whether this af-
fected the percentage of transmission by patients with
smear-negative TB.
In countries with a high incidence of TB, microscopic ex-
amination of sputum smear samples is often the only available
diagnostic test for TB. As a result, patients with smear-negative
TB do not receive a diagnosis in a timely manner; thus, disease
may further develop, initiation of treatment may be delayed,
and further TB transmission may occur [21]. Although it is
not known whether HIV-TB–coinfected patients for whom the
result of sputum smear is negative are as infectious as we found
in our study [17], our confirmatory finding that patients with
smear-negative TB can transmit TB has implications for coun-
tries where HIV infection is endemic. HIV infection and AIDS
are accompanied by high rates of smear-negative TB. For ex-
ample, 25%–61% of the HIV-infected patients with TB in sub-
Saharan Africa have smear-negative pulmonary TB [22]. More
emphasis should be placed on the development of better TB
diagnosis and the improvement of culture facilities in countries
with a high incidence of TB [23].
In conclusion, our study suggests that 12.6% of the TB trans-
mission in The Netherlands is caused by patients with smear-
negative pulmonary TB. Although sputum smear analysis re-
veals most of the patients with infectious TB, patients with
sputum smear–negative TB should not be considered to be
noninfectious. Therefore, we recommend that, in countries
with a low TB burden and sufficient public health resources,
contact investigation should be expanded to include patients
with smear-negative TB, in addition to patients with smear-
positive TB.
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